![Development of endocrine immune-related adverse events and improved survival in advanced melanoma patients treated with nivolumab monotherapy]()
Development of endocrine immune-related adverse events and improved survival in advanced melanoma patients treated with nivolumab monotherapyMaeda, Takuya; Yoshino, Koji; Nagai, Kojiro; Oaku, Satoe; Kato, Megumi; Hiura, Azusa; Hata, Hiroo · European Journal of Cancer · 2019